Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactive Visual Exploration of Rule-Based Model Logic.

IEEE transactions on visualization and computer graphics·2026
Same author

Detecting Stable Cross-Impact Patterns in Bivariate Time Series.

IEEE transactions on visualization and computer graphics·2026
Same author

Designing for Collaboration: Visualization to Enable Human-LLM Analytical Partnership.

IEEE computer graphics and applications·2025
Same author

Influence of Data Curation and Confidence Levels on Compound Predictions Using Machine Learning Models.

Journal of chemical information and modeling·2024
Same author

Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective.

Journal of medicinal chemistry·2024
Same author

Data-oriented protein kinase drug discovery.

European journal of medicinal chemistry·2024
Same journal

Graph Pattern Matching based reassembly - 3DGPM.

IEEE computer graphics and applications·2026
Same journal

Making Learning Visible: Turning Public Engagement into Evidence for Academic Learning.

IEEE computer graphics and applications·2026
Same journal

LlymX: Multimodal LLM-Augmented XR for Context-Aware Information Access.

IEEE computer graphics and applications·2026
Same journal

Dynamic Gaussian-Based Digital Twin Reconstruction of Articulated Multi-Joint Objects.

IEEE computer graphics and applications·2026
Same journal

Steiner and Poisson Traversal Initializations: Initial Curve Optimization for Geometric Flow-based Surface Filling.

IEEE computer graphics and applications·2026
Same journal

Insight Into the Insight Toolkit.

IEEE computer graphics and applications·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

From Prediction to Insight: Visual Analytics for Understanding Compound Potency Models.

Bahavathy Kathirgamanathan, Tiago Janela, Elena Xerxa

    IEEE Computer Graphics and Applications
    |May 27, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study transforms machine learning (ML) potency predictions into chemical insights. By converting ML models into rules and using visual analytics, researchers can uncover molecular features driving compound properties for drug discovery.

    Related Experiment Videos

    Last Updated: May 29, 2026

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
    13:54

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

    Published on: August 18, 2023

    Area of Science:

    • Medicinal Chemistry
    • Cheminformatics
    • Computational Chemistry

    Background:

    • Machine learning (ML) is integral to medicinal chemistry for predicting compound properties.
    • Accurate predictions are insufficient; understanding the underlying molecular features driving these properties is crucial for drug discovery.
    • Current methods lack robust ways to translate complex ML models into actionable chemical knowledge.

    Purpose of the Study:

    • To develop and demonstrate a workflow for extracting domain knowledge from trained ML models in medicinal chemistry.
    • To translate ML model predictions into chemically interpretable insights regarding compound potency.
    • To generate testable hypotheses about structure-activity relationships (SAR).

    Main Methods:

    • An application-oriented case study analyzing a trained ML model for compound potency.
    • Conversion of the ML model into a set of decision rules.
    • Application of topic-guided visual analytics to identify patterns in feature conditions associated with high predicted potency.
    • Mapping identified patterns back to molecular substructures to derive chemically relevant motifs.

    Main Results:

    • Successfully converted a predictive ML model into interpretable decision rules.
    • Identified co-occurring molecular feature conditions linked to high compound potency using visual analytics.
    • Generated chemically meaningful motifs and hypotheses regarding SAR from ML model insights.
    • Demonstrated the utility of combining rule-based representations, topic modeling, and visual exploration.

    Conclusions:

    • The presented workflow effectively transforms ML potency predictions into mechanistic insights for medicinal chemistry.
    • Combining rule-based models, topic modeling, and visual analytics provides a reusable approach for interpreting ML models of molecular properties.
    • This method enhances the utility of ML in drug discovery by providing interpretable SAR and guiding experimental design.